SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-035673
Filing Date
2022-12-16
Accepted
2022-12-16 08:30:27
Documents
15
Period of Report
2022-12-15
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 67280
2 PRESS RELEASE ex99-1.htm EX-99.1 24462
3 ex99-1_001.jpg GRAPHIC 14309
  Complete submission text file 0001493152-22-035673.txt   352973

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aeha-20221215.xsd EX-101.SCH 4404
5 XBRL DEFINITION FILE aeha-20221215_def.xml EX-101.DEF 27307
6 XBRL LABEL FILE aeha-20221215_lab.xml EX-101.LAB 37849
7 XBRL PRESENTATION FILE aeha-20221215_pre.xml EX-101.PRE 25927
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7169
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Aesther Healthcare Acquisition Corp. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 221466536
SIC: 2834 Pharmaceutical Preparations